These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7488878)

  • 1. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy.
    Heufelder AE
    Thyroid; 1995 Aug; 5(4):331-40. PubMed ID: 7488878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
    Heufelder AE
    Rev Endocr Metab Disord; 2000 Jan; 1(1-2):87-95. PubMed ID: 11704996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interactions of fibroblasts, adipocytes and immunocompeent cells in the pathogenesis of endocrine ophthalmopathy].
    Heufelder AE
    Acta Med Austriaca; 2001; 28(4):89-92. PubMed ID: 11593897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease.
    Heufelder AE; Wenzel BE; Scriba PC
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3733-9. PubMed ID: 8855831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of antigen receptor variable region repertoires in T lymphocytes infiltrating the intrathyroidal and extrathyroidal manifestations in patients with Graves' disease.
    Heufelder AE; Schworm HD; Wenzel BE; Garrity JA; Bahn RS
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():84-7. PubMed ID: 8981009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Graves' ophthalmopathy: recent controversies and progress.
    Heufelder AE
    Eur J Endocrinol; 1995 May; 132(5):532-41. PubMed ID: 7749490
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
    Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
    Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
    Prabhakar BS; Bahn RS; Smith TJ
    Endocr Rev; 2003 Dec; 24(6):802-35. PubMed ID: 14671007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications.
    Bartalena L; Tanda ML; Piantanida E; Lai A
    Biofactors; 2003; 19(3-4):155-63. PubMed ID: 14757966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of immune damage in Graves' ophthalmopathy.
    Hiromatsu Y; Wang PW; Wosu L; How J; Wall JR
    Horm Res; 1987; 26(1-4):198-207. PubMed ID: 3596469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy.
    Heufelder AE; Dutton CM; Sarkar G; Donovan KA; Bahn RS
    Thyroid; 1993; 3(4):297-300. PubMed ID: 7509671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue.
    Spitzweg C; Joba W; Hunt N; Heufelder AE
    Eur J Endocrinol; 1997 Jun; 136(6):599-607. PubMed ID: 9225723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection, localization and modulation of hyaluronic acid/CD44 receptor expression in patients with endocrine orbitopathy].
    Heufelder AE; Bahn RS; Boergen KP; Scriba PC
    Med Klin (Munich); 1993 Apr; 88(4):181-4, 277. PubMed ID: 8492772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of retroorbital T cell antigen receptor variable region gene usage in patients with Graves' ophthalmopathy.
    Heufelder AE; Herterich S; Ernst G; Bahn RS; Scriba PC
    Eur J Endocrinol; 1995 Mar; 132(3):266-77. PubMed ID: 7889172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation.
    Smith TJ
    Autoimmunity; 2003; 36(6-7):409-15. PubMed ID: 14669949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell restriction in thyroid eye disease.
    Heufelder AE
    Thyroid; 1998 May; 8(5):419-22. PubMed ID: 9623734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.